Publication:
The Potential Demand for an HIV/AIDS Vaccine in Brazil

Simple item page
dc.contributor.authorDutilh Novaes, Hillegonda Maria
dc.contributor.authorLuna, Expedito J.A.
dc.contributor.authorGoldbaum, Moises
dc.contributor.authorKilsztajn, Samuel
dc.contributor.authorRossbach, Anaclaudia
dc.contributor.authorde la Roca Carvalheiro, Jose
dc.date.accessioned2014-08-01T17:16:54Z
dc.date.available2014-08-01T17:16:54Z
dc.date.issued2002-12
dc.description.abstractThis study assesses the potential demand by the public sector for a preventive HIV/AIDS vaccine in Brazil and the costs of alternative strategies for a vaccination program. Brazil has a mature AIDS epidemic: the percent of the population living with HIV or AIDS (about 0.6 percent of adults) is not as high as in other severely affected developing countries, but infection rates in specific risk groups in the population are very high and HIV has spread beyond these groups into the general population of low-risk individuals. Preventive HIV/AIDS vaccines are still in the testing stage. The characteristics of the first vaccines developed, in terms of their efficacy, duration of effectiveness, ease of administration, and price, are still unknown. But the potential benefits of such a vaccine in Brazil would be high. The study reviews the cost and impact of HIV/AIDS in Brazil, in terms of disease and economic burden, as a proxy for the benefits of an HIV/AIDS vaccine. The epidemiology of AIDS and Brazil's experience with immunization coverage with other vaccines are used to assess the number of vaccines, delivery strategies, and possible costs of an HIV/AIDS immunization program in Brazil, assuming the availability of a 100 percent effective AIDS vaccine that lasts a lifetime under different pricing and dosing assumptions. A low-cost, highly effective vaccine would likely be affordable to an upper-middle-income country like Brazil and yield large benefits from a policy of universal, publicly subsidized immunization. But if prices are higher and the impact less favorable, the costs and effects would have to be compared with other AIDS prevention programs or other health interventions. Both political and economic considerations will likely figure into public policy on HIV/AIDS vaccination, when such a vaccine is developed.en
dc.identifierhttp://documents.worldbank.org/curated/en/2002/12/2113666/potential-demand-hivaids-vaccine-brazil
dc.identifier.doi10.1596/1813-9450-2940
dc.identifier.urihttps://hdl.handle.net/10986/19193
dc.languageEnglish
dc.language.isoen_US
dc.publisherWorld Bank, Washington, DC
dc.relation.ispartofseriesPolicy Research Working Paper;No. 2940
dc.rightsCC BY 3.0 IGO
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/igo/
dc.subjectACQUIRED IMMUNE DEFICIENCY SYNDROME
dc.subjectADHERENCE TO TREATMENT
dc.subjectADULT POPULATION
dc.subjectAGED
dc.subjectAIDS DEATHS
dc.subjectAIDS DISEASE
dc.subjectAIDS EPIDEMIC
dc.subjectAIDS INCIDENCE
dc.subjectAIDS MORBIDITY
dc.subjectAIDS MORTALITY
dc.subjectAIDS PANDEMIC
dc.subjectAIDS PREVENTION
dc.subjectAIDS TREATMENT
dc.subjectAIDS VACCINE
dc.subjectAIDS VACCINE R&D
dc.subjectANTIRETROVIRAL THERAPIES
dc.subjectAVERAGE AGE
dc.subjectBEHAVIORAL RISK
dc.subjectBLOOD SCREENING
dc.subjectCANCER
dc.subjectCITIES
dc.subjectCLINICAL AIDS
dc.subjectCONDOM DISTRIBUTION
dc.subjectCONDOM USE
dc.subjectCRACK
dc.subjectCURRENCY
dc.subjectDEATH RATE
dc.subjectDENTAL SERVICES
dc.subjectDIARRHEA
dc.subjectDISTRIBUTION OF CONDOMS
dc.subjectDRUGS
dc.subjectDRUGS USERS
dc.subjectECONOMICS
dc.subjectEFFECTIVE VACCINES
dc.subjectEPIDEMIOLOGICAL SURVEILLANCE
dc.subjectEPIDEMIOLOGY
dc.subjectEXPENDITURES
dc.subjectFAMILIES
dc.subjectFEMALE CONDOMS
dc.subjectFIRST SEXUAL INTERCOURSE
dc.subjectGDP PER CAPITA
dc.subjectHEALTH CARE
dc.subjectHEALTH INFORMATION
dc.subjectHEALTH INFORMATION SYSTEMS
dc.subjectHEALTH INSURANCE
dc.subjectHEALTH INSURANCE COVERAGE
dc.subjectHEALTH INTERVENTIONS
dc.subjectHEALTH POLICY
dc.subjectHEALTH PROMOTION
dc.subjectHEALTH SECTOR
dc.subjectHEALTH SERVICES
dc.subjectHETEROSEXUAL TRANSMISSION
dc.subjectHETEROSEXUALS
dc.subjectHIV
dc.subjectHIV INFECTION
dc.subjectHIV POSITIVE
dc.subjectHOME CARE
dc.subjectHOSPITALIZATION
dc.subjectHOSPITALS
dc.subjectHUMAN IMMUNODEFICIENCY VIRUS
dc.subjectIMMUNE DEFICIENCY
dc.subjectIMMUNITY
dc.subjectIMMUNIZATION
dc.subjectIMMUNIZATION COVERAGE
dc.subjectIMMUNODEFICIENCY
dc.subjectINCOME
dc.subjectINCOME DISTRIBUTION
dc.subjectINFECTIOUS DISEASES
dc.subjectINHABITANTS
dc.subjectINTERNATIONAL AIDS VACCINE INITIATIVE
dc.subjectINTERNATIONAL ORGANIZATIONS
dc.subjectINTERVENTION
dc.subjectINTRAVENOUS DRUG USERS
dc.subjectLIFE EXPECTANCY
dc.subjectMALE CONDOMS
dc.subjectMARKETING
dc.subjectNATIONAL HEALTH
dc.subjectNEW AIDS CASES
dc.subjectNEW CASES
dc.subjectNON-GOVERNMENTAL ORGANIZATIONS
dc.subjectNURSING
dc.subjectPANDEMIC
dc.subjectPATIENTS
dc.subjectPHARMACEUTICAL COMPANIES
dc.subjectPHYSICIANS
dc.subjectPOLICY DOCUMENTS
dc.subjectPOLICY RESEARCH
dc.subjectPPP
dc.subjectPREGNANCIES
dc.subjectPREMATURE DEATH
dc.subjectPREVENTIVE MEDICINE
dc.subjectPRIVATE HEALTH EXPENDITURES
dc.subjectPRIVATE INSURANCE
dc.subjectPRIVATE SECTOR
dc.subjectPUBLIC HEALTH
dc.subjectPUBLIC HEALTH SERVICES
dc.subjectPUBLIC SECTOR
dc.subjectPUBLIC SERVICES
dc.subjectPURCHASING POWER PARITY
dc.subjectQUALITY OF LIFE
dc.subjectRISK GROUPS
dc.subjectRISK REDUCTION
dc.subjectRISK REDUCTION INTERVENTIONS
dc.subjectSAFETY
dc.subjectSEX
dc.subjectSEX WITH MEN
dc.subjectSEXUAL INTERCOURSE
dc.subjectSEXUALLY ACTIVE
dc.subjectSEXUALLY TRANSMITTED INFECTIONS
dc.subjectTHERAPEUTIC INTERVENTIONS
dc.subjectTHERAPEUTIC MEASURES
dc.subjectTOTAL POPULATION
dc.subjectTRANSMISSION
dc.subjectUNAIDS
dc.subjectURBANIZATION
dc.subjectVACCINATION
dc.subjectVACCINE RESEARCH
dc.subjectVACCINE TRIALS
dc.titleThe Potential Demand for an HIV/AIDS Vaccine in Brazilen
dspace.entity.typePublication
okr.crossref.titleThe Potential Demand for an HIV/AIDS Vaccine in Brazil
okr.date.disclosure2002-12-31
okr.date.doiregistration2025-04-10T09:21:52.635583Z
okr.doctypePublications & Research::Policy Research Working Paper
okr.doctypePublications & Research
okr.docurlhttp://documents.worldbank.org/curated/en/2002/12/2113666/potential-demand-hivaids-vaccine-brazil
okr.globalpracticeHealth, Nutrition, and Population
okr.guid548151468770129650
okr.identifier.doi10.1596/1813-9450-2940
okr.identifier.externaldocumentum000094946_0301180436355
okr.identifier.internaldocumentum2113666
okr.identifier.reportWPS2940
okr.language.supporteden
okr.pdfurlhttp://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/2003/03/07/000094946_0301180436355/Rendered/PDF/multi0page.pdfen
okr.region.administrativeLatin America & Caribbean
okr.region.countryBrazil
okr.sectorHealth and other social services :: Health
okr.topicHealth, Nutrition and Population::HIV AIDS
okr.topicHealth Monitoring and Evaluation
okr.topicHealth, Nutrition and Population::Adolescent Health
okr.topicHealth Economics and Finance
okr.topicHealth, Nutrition and Population::Health Indicators
okr.topicDisease Control and Prevention
okr.topicEarly Child and Children's Health
okr.topicHealth, Nutrition and Population::Public Health Promotion
okr.unitPublic Services, Development Research Group
okr.volume1
relation.isSeriesOfPublication26e071dc-b0bf-409c-b982-df2970295c87
relation.isSeriesOfPublication.latestForDiscovery26e071dc-b0bf-409c-b982-df2970295c87
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
multi0page.pdf
Size:
2.05 MB
Format:
Adobe Portable Document Format
Download
No Thumbnail Available
Name:
multi0page.txt
Size:
96.78 KB
Format:
Plain Text
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description:
Download
Collections
Policy Research Working Papers